A guide to Medicare coverage for breast cancer diagnosis and treatment, including cost differences between Original Medicare ...

Routine annual changes to Medicare and Medicare Advantage plans, combined with sweeping federal spending cuts, mean that 2026 has developed into a turbulent year for the health insurance industry.

Crinetics Pharmaceuticals (NASDAQ:CRNX) executives highlighted early commercial momentum for PALSONIFY, outlined a global phase II/III study plan for atumelnant in ACTH-dependent Cushing’s syndrome ...

Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.

Past conflicts eroded Congress’s ability to decide when to go to war. Donald Trump’s attack on Iran destroyed it.

LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a ...

Adjusted EBITDA for the fourth quarter of 2025 increased to $12.0 million compared to $8.8 million in the same period of 2024. Adjusted EBITDA for the full year of 2025 came in at $24.3 million ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...

Physician assistants or PAs in SC want more freedom to practice and less bureaucracy. Doctors want better partnerships but ...

"Think about where you want to apply AI – documentation, patient engagement, revenue cycle, clinical trials – and go talk to ...

March 20, 2026 PDUFA goal date for sNDA for setmelanotide in acquired hypothalamic obesity -- BOSTON, March 01, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global ...